A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could ...

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced that it has been honored with the Research and ...

Learn the hidden signs of sleep apnea, its impact on health, and how effective treatment can restore your energy and improve ...

Obese patients with type 2 diabetes are less likely to need a CPAP machine to treat sleep apnea if they’re taking a GLP-1 ...

You can live for years with obstructive sleep apnea and never know it. The condition repeatedly narrows your upper airway during sleep. That can break up your rest, strain your body, and lower oxygen ...

(CNN) — Maybe you know you snore like a bear, but you don’t feel much urgency to look into it. Or maybe you have been told to wear a continuous positive airway pressure, or CPAP, machine for sleep ...

Respiratory and sleep medicine physicians share collaborative measures to diagnose and treat comorbid sleep disorders and ...

Biotech firm Apnimed plans to seek FDA approval for its sleep apnea drug, with market availability expected by 2027 ...

Patients with obstructive sleep apnea appear to be at greater risk for kidney and bladder cancer. Obstructive sleep apnea is associated with a higher risk for kidney and bladder cancer, but not ...

A new study finds that having obstructive sleep apnea increases the risk that a person will eventually develop Parkinson’s disease, and the more severe the apnea, the higher the risk. CPAP therapy ...

About one in nine adults suffer from chronic insomnia and its residual effects like drowsiness, cognitive issues, and irritability, as well as increased health risks like diabetes and heart risks if ...